2010Hebei Journal of Traditional Chinese MedicineRequires access

Protection of Zhiganqing capsule on non-alcoholic fatty liver in rat

Chang Li

Open publisher page 0 citations

Abstract

Objective To study the protection of Zhiganqing capsule on non-alcoholic fatty liver in rat. Methods 50 SD rats were randomly divided into control group, model group, Aciclovir group and Zhiganqing capsule (H, L two dosage groups). High fat feed was applied in model group, Aciclovir group and Zhiganqing capsule. The course was eight weeks. At same time of establishment of model, equivalent drugs were taken in different groups. TC,TG, FFA and liver function were observed. The pathology of hepatic tissue was also observed. Results Zhiganqing capsule can decrease TC, TG, ALT and AST in serum of rat with non-alcoholic fatty liver.Conclusion Zhiganqing capsule has adjusting blood lipid, liver protection, reducing aminotransferase and protection of non-alcoholic fatty liver.

About this research paper

What this paper is about

Objective To study the protection of Zhiganqing capsule on non-alcoholic fatty liver in rat. Methods 50 SD rats were randomly divided into control group, model group, Aciclovir group and Zhiganqing capsule (H, L two dosage groups). High fat feed was applied in model group, Aciclovir group and Zhiganqing capsule. The course was eight weeks. At same time of establishment of model, equivalent drugs were taken in different groups. TC,TG, FFA and liver function were observed. The pathology of hepatic tissue was also observed. Results Zhiganqing capsule can decrease TC, TG, ALT and AST in serum of rat with non-alcoholic fatty liver.Conclusion Zhiganqing capsule has adjusting blood lipid, liver protection, reducing aminotransferase and protection of non-alcoholic fatty liver.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the protection of Zhiganqing capsule on non-alcoholic fatty liver in rat. Methods 50 SD rats were randomly divided into control group, model group, Aciclovir group and Zhiganqing capsule (H, L two dosage groups). High fat feed was applied in model group, Aciclovir group and Zhiganqing capsule. The course was eight weeks. At same time of establishment of model, equivalent drugs were taken in different groups. TC,TG, FFA and liver function were observed. The pathology of hepatic tissue was also observed. Results Zhiganqing capsule can decrease TC, TG, ALT and AST in serum of rat with non-alcoholic fatty liver.Conclusion Zhiganqing capsule has adjusting blood lipid, liver protection, reducing aminotransferase and protection of non-alcoholic fatty liver.

Key concepts: Capsule, Fatty liver, Medicine, Alcoholic fatty liver, Internal medicine, Liver function, Gastroenterology, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Protection of Zhiganqing capsule on non-alcoholic fatty liver in rat — Research Paper | ScholarLens